Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PDD Holdings Inc. American Depositary Shares (PDD) vs BIO-TECHNE Corp (TECH) Price & Performance

PDD Holdings Inc. American Depositary SharesTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

PDD Holdings Inc. American Depositary Shares vs BIO-TECHNE Corp — how do they compare? PDD Holdings Inc. American Depositary Shares trades at $78.7 (market cap $111.74B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: PDD Holdings Inc. American Depositary Shares is far larger — about 9.8× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while PDD Holdings Inc. American Depositary Shares pays none. Which is the better fit depends on your goals.

PDDTECH
Market Cap
$111.74B$11.37B
Volume
4,029,8693,153,511
Sector
Consumer CyclicalHealth
52-Week High
$138.13$72.61
52-Week Low
$73.30$43.31
Enterprise Value
$44.39B$11.40B
Typical Hold Time
—63 Days
Dividend Yield
—0.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PDD Holdings Inc. American Depositary Shares

No Aura AI signal available yet.

BIO-TECHNE Corp

TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.

Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About PDD Holdings Inc. American Depositary Shares

PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. Its sourcing, logistics, and fulfillment network supports those businesses and their commerce operations.

Read more on PDD →

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH →